Routine Health Screening Market

Report Highlights

The global market for routine health screening is expected to grow from $59.7 billion in 2024 and is projected to reach $82.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 6.8% during the forecast period of 2024 to 2029.

Report Includes

• 37 data tables and 39 additional tables
• An overview of the global market for routine health screening
• Analysis of global market trends, featuring revenue data for 2021-2023, estimates for 2024, forecasts for 2029 and projected CAGRs through 2029
• Evaluation of the current market’s size and revenue growth prospects, along with a market share analysis by test type, sample type, technology, and region
• A look at recent innovations, technological advances, and product launches in the market
• Analysis of the industry’s regulatory framework and policies
• A discussion of ESG challenges and practices in the routine health screening industry
• An analysis of the key companies’ market shares, proprietary technologies, alliances, and other strategies
• A discussion of key patents
• Profiles of the leading players, including Quest Diagnostics, Laboratory Corporation of America Holdings, Sonic Healthcare Ltd., Eurofins Scientific, and SYNLAB AG

Report Scope

The routine health screening market presents a vast and promising opportunity as it responds to evolving healthcare trends and societal needs. With an increasing emphasis on preventive healthcare, routine health screenings have become instrumental in detecting potential health issues at early stages. The market’s expansion is propelled by the rising incidence of non-communicable diseases, such as diabetes and cardiovascular disorders, coupled with the aging global population, necessitating proactive health management strategies. Technological advancements, including innovations in diagnostic tools and the integration of artificial intelligence, enhance the accuracy and accessibility of screenings, catering to a broader demographic. The aftermath of the COVID-19 pandemic has further underscored the importance of regular health check-ups, reinforcing the significance of routine health screenings.

Additionally, incorporating these screenings into corporate wellness programs and the trend toward personalized medicine further amplifies the market’s potential. The routine health screening market is poised for substantial expansion, playing a pivotal role in the proactive and personalized management of individual health globally. This report presents insights into this market’s current and future potential, drivers, challenges, opportunities, industry status, developments, market trends, geographical challenges, and strategies (e.g., mergers, acquisitions, collaborations). The report informs all market players, potential entrants, government agencies, and other interested parties. The report covers geographic regions in detail, so companies interested in expanding their geographic reach will also find this study helpful.

Analyst Credentials

BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.

Consulting Editor’s Credentials

Christian Goodwin, MD, MPH, is a resident physician at Duke University. He completed his undergraduate degree at the University of Virginia. He obtained his MPH at the University of Liverpool as a US-UK Fulbright Scholar while serving as a visiting researcher at the Palliative Care Institute Liverpool. He obtained his MD from the University of North Carolina as a Blanchard Scholar. Christian has expertise in health systems innovation, public health research, geriatrics, and psychiatry.